|
WIPI2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.277100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.495100E-03 |
| Normal-vs-Stage2 |
7.328400E-01 |
| Normal-vs-Stage3 |
7.838900E-03 |
| Normal-vs-Stage4 |
8.968900E-04 |
| Stage1-vs-Stage2 |
5.460400E-02 |
| Stage1-vs-Stage3 |
7.384200E-01 |
| Stage1-vs-Stage4 |
2.027600E-01 |
| Stage2-vs-Stage3 |
5.522300E-02 |
| Stage2-vs-Stage4 |
1.811840E-02 |
| Stage3-vs-Stage4 |
3.416000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.219800E-03 |
| Normal-vs-AfricanAmerican |
1.520190E-01 |
| Normal-vs-Asian |
2.126200E-02 |
| Caucasian-vs-AfricanAmerican |
5.366600E-01 |
| Caucasian-vs-Asian |
9.821200E-01 |
| AfricanAmerican-vs-Asian |
6.095200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.499700E-02 |
| Normal-vs-Female |
4.240500E-03 |
| Male-vs-Female |
2.245600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.060300E-03 |
| Normal-vs-Age(41-60Yrs) |
6.918400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.251820E-02 |
| Normal-vs-Age(81-100Yrs) |
2.681900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.542400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.989000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.638800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.366000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.338000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.589000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.736000E-02 |
| Classical-VS-Follicular |
8.728200E-02 |
| Classical-VS-Other |
4.815400E-01 |
| Classical-VS-Normal |
5.025700E-02 |
| Tall-VS-Follicular |
7.046600E-01 |
| Tall-VS-Other |
9.719400E-01 |
| Tall-VS-Normal |
7.972600E-04 |
| Follicular-VS-Other |
9.186000E-01 |
| Follicular-VS-Normal |
4.016800E-03 |
| Other-VS-Normal |
1.340580E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.239600E-02 |
| Normal-vs-N1 |
1.33840000005048E-06 |
| N0-vs-N1 |
2.188300E-04 |
|
|
